Cointime

VitaDAO

company

About

A decentralized collective funding early stage aging research & spinning out longevity biotech startups to extend healthy lifespan

Highlights

Total Funding Amount
$5.60M
Funding Rounds
2
Investors
1
Employee Profiles
5

Details

Last Funding Type
Seed
Last Funding Money Raised
$500K
Industries
Biotechnology,Blockchain,Life Science,Pharmaceutical
Founded date
Jan 1, 2021
Operating Status
Active

VitaDAO is a decentralized collective funding early stage longevity research
Our mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.

VitaDAO and its members are committed to nurturing and developing the intellectual property, licenses, and data sets that result from the projects it supports.

Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$5.60M
VitaDAO has raised a total of $5.60M in funding over 2 rounds. Their latest funding was raised on Aug 28, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 28, 2022 Seed $500K 1 Pfizer Venture Investments — Detail
Jun 23, 2021 Pre-seed $5.10M — — — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
VitaDAO is funded by 1 investors. Pfizer Venture Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Venture Investments Yes Seed

Employee Profiles

Number of Employee Profiles
5
VitaDAO has 5 current employee profiles, including Advisor Paul Kohlhaas
Paul Kohlhaas
Advisor
Laurence Ion
Executive
Tim Peterson
Executive
Alex Dobrin
Employee
Cointime
Content
Company